slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 45,721-45,750
Pages 2,019
Rows per page 30
Component
45,721-45,750 of 60,568
07
The slide uses a structured grid to map high-level strategic goals to specific clinical assets.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
15
The slide uses a checkmark/cross comparison matrix to demonstrate the superiority of QCS over IHC.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
25
The slide presents clinical trial baseline data for two study arms.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
26
Includes a table of clinical trial statistics (events, median EFS, HR, P-value) and a risk table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
28
Includes 'No. of patients at risk' table and statistical summary table.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
29
Forest plot showing hazard ratios with 95% confidence intervals for multiple clinical subgroups.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
30
The table compares safety data across various categories of adverse events, including grade 3/4, serious AEs, and treatment-related outcomes.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
34
The slide uses a market segmentation approach to map clinical trials (NIAGARA, POTOMAC, VOLGA, NILE) to patient populations (NMIBC, MIBC, 1L mUC).AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
45
WCLC conference presentation slide. Includes waterfall plot and summary table of ORR and treatment continuation.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
53
The slide uses a grid layout to categorize clinical trials by disease stage and patient population, highlighting established standards of care (SoC) with hatched patterns.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
54
The slide uses a matrix structure to categorize clinical trials (e.g., DESTINY-Breast, TROPION-Breast, CAPItello) by patient population and treatment line.AstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
55
AstraZeneca | Investor Event Presentation Deck | 55 slidesAstraZeneca | Investor Event Presentation Deck | 55 slides · AstraZeneca
Conference presentation Investor relations 1 hit
07
The slide uses a split-screen layout to contrast partnership-based revenue with internal pipeline development.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
13
The slide uses a Gantt-style chart to show the progress of different drug programs. It distinguishes between proprietary (teal) and partner (yellow) pipelines.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
15
The slide uses a table to demonstrate market validation for early-stage IBD assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations Beat · Market Size1 hit
25
The slide uses a table format to demonstrate differentiation and market potential for five specific pipeline assets.BenevolentAI | Investor Presentation Deck | 31 slides · BenevolentAI
Pitch deck Investor relations 1 hit
12
The slide uses a comparison framework to distinguish between agency-based platform business and principal-based integrated verticals.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Solution1 hit
14
The table highlights that despite different operational models, the gross profit margins are relatively consistent (7-10%).Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Solution1 hit
21
The slide uses a table-based layout to compare regional performance metrics against global totals.Delivery Hero | Investor Presentation Deck | 54 slides · Delivery Hero
Conference presentation Investor relations Beat · Market Size1 hit
15
Includes non-GAAP reconciliation footnote.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
Kenvue | Results Presentation Deck | 37 slidesKenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations Beat · Action1 hit
21
The table uses a timeline-like structure to show the duration of specific business drivers across the four quarters of 2023.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
26
Includes detailed reconciliation of non-GAAP measures to GAAP income before taxes.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
31
The table shows adjustments for special items, impairment, carve-out methodology, deferred markets, foreign tax credits, and other items.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
32
Non-GAAP financial measure reconciliation.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
33
The table provides a bridge between GAAP and non-GAAP financial metrics.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
34
Non-GAAP financial measure reconciliation.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
36
Data is in millions of dollars and is unaudited.Kenvue | Results Presentation Deck | 37 slides · Kenvue
Conference presentation Investor relations 1 hit
11
The table provides a detailed breakdown of adjustments including stock-based compensation, impairment of intangible assets, and acquisition-related expenses.Playtika | Results Presentation Deck | 12 slides · Playtika
Conference presentation Investor relations Beat · Evidence1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Action1 hit